Liarozole
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
6-[(3-Chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole
|
|
Identifiers | |
115575-11-6 | |
3D model (Jmol) | Interactive image |
ChemSpider | 54664 |
5210 | |
PubChem | 60652 |
|
|
|
|
Properties | |
C17H13ClN4 | |
Molar mass | 308.77 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Liarozole is a retinoic acid metabolism-inhibiting chemical.[1]
Synthesis[edit]
References[edit]
- ^ Vahlquist, A; Blockhuys, S; Steijlen, P; Van Rossem, K; Didona, B; Blanco, D; Traupe, H (2013). "Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial". The British journal of dermatology. 170 (1): 173–81. doi:10.1111/bjd.12626. PMID 24102348.
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |